Contact
Please use this form to send email to PR contact of this press release:
CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders
TO:
Please use this form to send email to PR contact of this press release:
CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders
TO: